FIGS (NYSE:FIGS) Sets New 52-Week High Following Better-Than-Expected Earnings

FIGS, Inc. (NYSE:FIGS)’s share price hit a new 52-week high during mid-day trading on Friday after the company announced better than expected quarterly earnings. The company traded as high as $12.66 and last traded at $12.60, with a volume of 9780949 shares. The stock had previously closed at $10.96.

The company reported $0.10 EPS for the quarter, beating analysts’ consensus estimates of $0.02 by $0.08. FIGS had a return on equity of 8.62% and a net margin of 5.43%.The firm had revenue of $201.90 million during the quarter, compared to the consensus estimate of $165.33 million. During the same quarter in the prior year, the business posted $0.01 earnings per share. FIGS’s revenue for the quarter was up 33.0% on a year-over-year basis.

Key Stories Impacting FIGS

Here are the key news stories impacting FIGS this week:

• Positive Sentiment: Q4 earnings beat — FIGS reported $0.10 EPS vs. $0.02 consensus and revenue of $201.9M (up 33% YoY), signaling solid top-line momentum and margin expansion. Article Title
• Positive Sentiment: Aggressive FY2026 revenue guide — management is targeting roughly $694M–$707M (around a $700M target cited publicly), well above Street consensus (~$625.6M), and flagged international expansion and margin improvement as priorities. That guidance materially raises growth expectations. Article Title
• Positive Sentiment: Analyst upgrade — KeyCorp moved FIGS from sector weight to overweight with a $17 price target, providing third‑party validation of the company’s growth trajectory. Article Title
• Neutral Sentiment: Telsey raised its price target from $9 to $15 and set a “market perform” rating — upgrade in target, but PT sits slightly below the current share price. Article Title
• Neutral Sentiment: BTIG reaffirmed a “buy” rating with a $15 target — keeps buy conviction but target is not above the current price, limiting near-term upside from that shop. Article Title
• Neutral Sentiment: Conference call and analyst write-ups published — transcripts and call highlights provide detail on Olympic partnership, international rollout and margin levers for investors doing deeper diligence. Article Title
• Negative Sentiment: Valuation and mixed price-targets risk — FIGS trades with a high P/E and recently hit a 12‑month high, leaving shares vulnerable to profit-taking; several widely cited targets (~$15) sit at or below the current price. Article Title

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the stock. Wolfe Research upgraded shares of FIGS to a “buy” rating in a research note on Wednesday, December 10th. The Goldman Sachs Group raised shares of FIGS from a “strong sell” rating to a “hold” rating in a report on Friday. KeyCorp upgraded shares of FIGS from a “sector weight” rating to an “overweight” rating and set a $17.00 target price on the stock in a research note on Friday. Zacks Research upgraded FIGS from a “hold” rating to a “strong-buy” rating in a research note on Friday, November 7th. Finally, Telsey Advisory Group boosted their price objective on FIGS from $9.00 to $15.00 and gave the company a “market perform” rating in a report on Friday. Two investment analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $12.25.

Insider Activity

In related news, CEO Catherine Eva Spear sold 49,734 shares of the business’s stock in a transaction dated Tuesday, January 6th. The shares were sold at an average price of $11.38, for a total transaction of $565,972.92. Following the completion of the sale, the chief executive officer owned 1,857,299 shares of the company’s stock, valued at $21,136,062.62. This represents a 2.61% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Sarah Oughtred sold 22,690 shares of the stock in a transaction dated Thursday, February 5th. The stock was sold at an average price of $10.56, for a total transaction of $239,606.40. Following the sale, the chief financial officer owned 821,500 shares in the company, valued at approximately $8,675,040. This trade represents a 2.69% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 105,813 shares of company stock valued at $1,168,051. Company insiders own 29.44% of the company’s stock.

Institutional Trading of FIGS

Hedge funds have recently made changes to their positions in the stock. Elevated Capital Advisors LLC acquired a new position in FIGS during the 4th quarter valued at approximately $45,000. Assetmark Inc. bought a new stake in FIGS in the third quarter valued at $35,000. Kemnay Advisory Services Inc. bought a new stake in FIGS in the fourth quarter valued at $69,000. Quarry LP boosted its holdings in shares of FIGS by 1,876.3% during the third quarter. Quarry LP now owns 7,846 shares of the company’s stock valued at $52,000 after acquiring an additional 7,449 shares during the period. Finally, Capstone Financial Advisors Inc. bought a new position in shares of FIGS during the second quarter worth about $56,000. Institutional investors own 92.21% of the company’s stock.

FIGS Stock Performance

The stock’s fifty day moving average is $11.39 and its two-hundred day moving average is $9.37. The firm has a market cap of $2.54 billion, a price-to-earnings ratio of 81.24 and a beta of 1.29.

About FIGS

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.